Endocannabinoids in basal ganglia circuits - Implications for Parkinson disease

被引：70

作者：

Benarroch, Eduardo ^{[1
]}

机构：

[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA

来源：

NEUROLOGY | 2007年 / 69卷 / 03期

关键词：

D O I：

10.1212/01.wnl.0000267407.79757.75

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：306 / 309

页数：4

共 23 条

[1] CB1 cannabinoid receptor signalling in Parkinson's disease
Brotchie, JM
[J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (01) : 54 - 61
[2] Cannabis for dyskinesia in Parkinson disease - A randomized double-blind crossover study
Carroll, CB
Bain, PG
Teare, L
Liu, X
Joint, C
Wroath, C
Parkin, SG
Fox, P
Wright, D
Hobart, J
Zajicek, JP
[J]. NEUROLOGY, 2004, 63 (07) : 1245 - 1250
[3] Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity:: in vivo and in vitro evidence
de Lago, E
de Miguel, R
Lastres-Becker, I
Ramos, JA
Fernández-Ruiz, J
[J]. BRAIN RESEARCH, 2004, 1007 (1-2) : 152 - 159
[4] Circuits and circuit disorders of the basal ganglia
DeLong, Mahlon R.
Wichmann, Thomas
[J]. ARCHIVES OF NEUROLOGY, 2007, 64 (01) : 20 - 24
[5] Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse
Engler, B
Freiman, I
Urbanski, M
Szabo, B
[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (02) : 608 - 617
[6] Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism
Fernandez-Espejo, E
Caraballo, I
de Fonseca, FR
El Banoua, F
Ferrer, B
Flores, JA
Galan-Rodriguez, B
[J]. NEUROBIOLOGY OF DISEASE, 2005, 18 (03) : 591 - 601
[7] Fernández-Ruiz J, 2005, HANDB EXP PHARMACOL, V168, P479
[8] Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease
Fox, SH
Henry, B
Hill, M
Crossman, A
Brotchie, J
[J]. MOVEMENT DISORDERS, 2002, 17 (06) : 1180 - 1187
[9] Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice
González, S
Mena, MA
Lastres-Becker, I
Serrano, A
de Yébenes, JG
Ramos, JA
Fernández-Ruiz, J
[J]. BRAIN RESEARCH, 2005, 1046 (1-2) : 195 - 206
[10] Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia
Julian, MD
Martin, AB
Cuellar, B
De Fonseca, FR
Navarro, M
Moratalla, R
Garcia-Segura, LM
[J]. NEUROSCIENCE, 2003, 119 (01) : 309 - 318

← 1 2 3 →